Disparities found in lung cancer care, survival in U.S. versus England
Despite steady declines in death rates in recent years, lung cancer remains the leading cause of cancer deaths in wealthy countries. In a new study, Yale researchers collaborated with investigators in Europe to examine lung cancer care and survival rates for patients with one of the most common forms of the disease.
Aging impairs innate immune response to flu
Aging impairs the immune system’s response to the flu virus in multiple ways, weakening resistance in older adults, according to a Yale study. The research reveals why older people are at increased risk of illness and death from flu, the researchers said.
Shorter quarantines with careful testing may be more effective than two-week isolation, Yale study finds
Appropriately timed testing can make a seven-day quarantine more effective than a 14-day quarantine in preventing the spread of COVID-19, according to a Yale School of Public Health study.Source: Yale Daily News
One-week Quarantine? It’s Possible, YSPH Finds
Up to now, a 14-day quarantine has been the conventional standard for stopping COVID-19 transmission in its tracks. In a new study from Yale School of Public Health that has been published in pre-print, researchers suggest a week-long waiting period could prove just as effective.
Dr. Donna Spiegelman is the Director of the New MS and PhD Biostatistics specialization in "Implementation and Prevention Science Methods" at the Yale School of Public Health
We have recently developed a specialization in ”Implementation and Prevention Science Methods” that all MS and PhD Biostatistics students matriculating this fall will be able to choose. If you plan to attend Yale you will be able to choose this specialization or the regular Biostatistics curriculum. You will have until the beginning of the spring term to decide which specialization you wish to follow. To help you make this decision there will be information sessions on the MS and PhD programs during the fall term with the Director of this specialization, Dr. Donna Spiegelman.
Seventh Annual Yale Day of Data on Friday, Dec. 6
The 2019 Yale Day of Data centers on the theme of Data Privacy, which emphasizes the challenges of balancing abundant information and openness in research with concerns about privacy and surveillance. It will be held at Yale Law School on December 6.
Digital Health Seminar Series Continues on May 15 with "Consumer Technologies: An Untapped Opportunity in Health Care"
This talk, by Google Fit's medical lead, Kapil Parakh, MD, MPH, PhD, will walk through the process of making an evidence-based app and challenges in bridging the worlds of scientific validity and user delight.
Next Talk in CBDS Seminar Series Will Be Wednesday, May 1
Please join us on Wednesday, May 1, at 4:00 p.m. in Brady Auditorium for the next CBDS Seminar Series guest speaker, Purvesh Khatri, PhD, from Stanford University. His talk is titled “Generalizability Through Heterogeneity in Translational Medicine.”
Antiretroviral Therapy Crucial in Preventing non-Hodgkin Lymphoma, YSPH Study Reinforces
A research team led by the Yale School of Public Health has found that for people living with HIV/AIDS, both recent immunosuppression and prolonged HIV viremia play important and independent roles in the development of non-Hodgkin lymphoma.
Novel YSPH Framework Helps Identify Genes Associated with Disease
A powerful analytical tool, known as UTMOST, developed by Hongyu Zhao, Ph.D., the Ira V. Hiscock Professor of Biostatistics at the Yale School of Public Health, and colleagues could allow researchers to design therapeutic drugs that more effectively combat disease.
Center for Biomedical Data Science Monthly Seminar Series Continues on Nov. 7
The next event in the Center for Biomedical Data Science's monthly seminar series, on Wednesday, Nov. 7, will feature a talk by Bobak Mortazavi, PhD, of Texas A&M University, with a focus on monitoring patients with such conditions as heart failure.